Table 1 Clinical information about the patients within the pedigree

From: Dysregulation of N-terminal acetylation causes cardiac arrhythmia and cardiomyopathy

ID

Genetics

Age of Dx.

Age at Death

Age at Last Eval.

Cause of Death

QT prolongation

Arrhythmia

Med.

Cardio-myopathy

NDDs

Other Clinical Phenotypes

II:2

NAA10 p.R4S

> 40 yrs

N/A

> 40 yrs

N/A

Yes, QTc 450-480 ms

No

Unknown

Normal echo

None

None known

II:5

NAA10 p.R4S

18 – 40 yrs

N/A

> 40 yrs

N/A

Unknown

Unknown

Beta Blocker

Unknown

Mild cognitive delay

Unknown

III:1

NAA10 p.R4S

18 – 40 yrs

N/A

18 – 40 yrs

N/A

Yes, QTc = 480 - 500 ms

Yes, intermittent VT, ICD implanted

Beta Blocker, SCB

Yes, RCM and LVNC

Yes, ASD and LDs

Proximity muscle weakness

III:6

KCNH2 p.R164H NAA10 p.R4S (inferred)

5 - 18 yrs

18 – 40 yrs

N/A

Sudden Cardiac Death

Yes, QTc 450-480 ms

Unknown

Beta Blocker

Normal echo

None

None

III:8

NAA10 p.R4S

5 - 18 yrs

5 - 18 yrs

N/A

Heart failure

Yes, QTc > 500 ms

Yes, VT/VF, multiple shocks from ICD

Beta Blocker, SCB

Yes, DCM, EF = < 30%

Yes, ASD and LDs

Proximity muscle weakness

III:9

Unknown

N/A

<5 yrs

N/A

Respiratory distress

Unknown

Unknown

Unknown

Unknown

Unknown

Unknown

III:11

Unknown

N/A

<5 yrs

N/A

?myocarditis

Unknown

Unknown

Unknown

Unknown

Unknown

Unknown

IV:3

KCNH2 p.R164H

<5 yrs

N/A

5 - 18 yrs

N/A

No, QTc <450 ms

No

None

Normal echo

None

None

IV:4

KCNH2 p.R164H NAA10 p.R4S

<5 yrs

N/A

5 - 18 yrs

N/A

Yes, QTc > 500 ms

Yes, intermittent PVCs, ILR implanted

Beta Blocker

Normal echo

Yes, speech delays and LDs

Feeding difficulties

  1. ASD Autism spectrum disorder, DCM Dilated cardiomyopathy, Dx Diagnosis, Echo Echocardiogram, EF Ejection fraction, Eval Evaluation, ICD Implantable cardioverter-defibrillator, ILR Implantable loop recorder, LDs Learning disabilities, LVNC Left ventricular non-compaction, Med Medications, N/A Not applicable, NDDs Neurodevelopmental disabilities, QTc Corrected QT interval, RCM Restrictive cardiomyopathy, VF Ventricular fibrillation, VT Ventricular tachycardia, SCB Class 1B sodium channel blocker.